This is a news story, published by USA Today, that relates primarily to GLP-1s news.
For more GLP-1s news, you can click here:
more GLP-1s newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from USA Today, you can click here:
more news from USA TodayOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss news, appetite news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
food cravingsUSA Today
•Health
Health
75% Informative
A new study is the first to map out all the potential benefits and risks associated with GLP-1s .
The drugs are associated with a lower risk of heart attack, stroke and other cardiovascular problems.
People who took the medicines also had fewer seizures and addictions to alcohol, cannabis and opioids.
On the flip side, the drugs are also associated with an increased risk of several negative health outcomes.
VR Score
74
Informative language
72
Neutral language
53
Article tone
semi-formal
Language
English
Language complexity
52
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links